UNITED CAPITAL FINANCIAL ADVISORS, LLC
Position in GILD — Gilead Sciences, Inc.
CIK 1463217
IRVING, TX
Position in GILD
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$13,663,923
-$6,501,243 QoQ
Shares Held
108,152
-25.3% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#380
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026UNITED CAPITAL FINANCIAL ADVISORS, LLC holds $392,709,829 across 14 Drug Manufacturers - General names. GILD ranks #8 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
74,694 | $89,590,231 | |
| 2 | JNJ |
Johnson & Johnson
|
345,519 | $87,751,460 | |
| 3 | ABBV |
AbbVie Inc.
|
254,843 | $64,128,692 | |
| 4 | NVO |
Novo Nordisk A S
|
1,000,682 | $47,972,695 | |
| 5 | AMGN |
Amgen Inc
|
90,846 | $32,897,153 | |
| 6 | MRK |
Merck & Co., Inc.
|
142,059 | $18,254,581 | |
| 7 | NVS |
Novartis AG
|
89,770 | $14,068,754 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
108,152 | $13,663,923 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,663,923 | 108,152 | Shares | Defined | 2026-08-17 | |
| 2026-03-31 | $20,165,166 | 144,688 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $20,965,342 | 170,811 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $19,713,156 | 177,596 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $20,099,733 | 181,291 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $21,181,259 | 189,034 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $18,775,218 | 203,261 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $20,655,157 | 246,364 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $17,438,329 | 254,166 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $19,417,622 | 265,087 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $24,578,758 | 303,404 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $45,488,879 | 607,004 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $50,225,285 | 651,684 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $56,460,172 | 680,489 | Shares | Defined | 2023-08-15 | |
| 2022-12-31 | $59,567,365 | 693,854 | Shares | Defined | 2023-02-15 | |
| 2022-09-30 | $44,022,971 | 713,616 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $43,714,442 | 707,239 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $42,016,703 | 706,757 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $50,538,375 | 696,025 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $46,706,669 | 668,671 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $44,740,407 | 649,730 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $39,774,336 | 615,416 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $34,301,798 | 588,771 | Shares | Defined | 2021-02-17 | |
| 2020-09-30 | $34,038,241 | 538,665 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $37,454,007 | 486,795 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $33,978,868 | 454,506 | Shares | Defined | 2020-08-11 | |
| No filing history on record for this holder in this stock. | ||||||